Broken String Biosciences logo

Broken String Biosciences

Recent Finacing

Series A

Recent Raise

$15M


Broken String Biosciences is a genomics company that develops safer cell and gene therapies by using its INDUCE-seq DNA break mapping technology to measure off-target effects in clinically relevant cells, aiming to enhance the efficiency, safety, and affordability of cell and gene therapies.

Total Funding

$15M

Headquarters

Cambridge, United Kingdom

Founded

N/A

Focus Areas

Genomics
Cell and Gene Therapies
Next Generation Sequencing

Investors

Illumina Ventures logo
Dieter von Holtzbrinck Ventures logo
Mérieux Equity Partners logo
Tencent logo
HERAN Partners logo